AMD's Dual-Engine Rally: Data Center Growth and $44 Billion CPU Thesis Propel Stock to 52-Week High

Advanced Micro Devices capped a blistering May with a fresh 52-week high of €444.80, but the real story isn't just the share price — it's the structural shift in data center architecture that Wolfe Research believes could unlock an extra $7 per share in earnings by 2028. The brokerage argues AMD is the best-positioned chipmaker to capture the emerging market for "agentic AI" CPUs, a thesis that puts a $44 billion revenue prize on the table for server processors alone by the end of the decade.

The stock closed Friday at €442.95, a fractional 0.42% decline on the day but still up nearly 10% for the week and a staggering 132% year-to-date in euro terms. The rally finds firm footing in the first-quarter numbers: revenue hit $10.25 billion, a 38% jump from a year earlier, with the data center segment surging 57% to $5.775 billion. Hyperscalers including Meta and OpenAI are ramping deployments of AMD's MI450 series, and Oracle is already running a 27,000-node cluster that is generating recurring revenue.

Wolfe Research's central thesis rests on a fundamental redesign of server rooms. As AI systems shift from training to inference and orchestration, the need for CPUs to coordinate complex workloads, manage memory, and route tasks across GPUs is growing dramatically. The firm reckons the server CPU market could expand 30% by 2028, with agentic and orchestrating processors alone accounting for a $44 billion total addressable market — up from a projected $17 billion in 2026. That could lift AMD's earnings power to between $25 and $30 a share in four years, versus about $7 of incremental EPS from the AI CPU opportunity alone.

Should investors sell immediately? Or is it worth buying AMD?

Yet the path is anything but a straight line. Wolfe flags a critical bottleneck: TSMC's production capacity remains tight and could become the deciding factor in the competitive race, potentially overshadowing pure performance advantages. Meanwhile, ARM-based CPUs are poised to capture between 50% and 75% of the agentic AI CPU market, threatening AMD's x86 stronghold. Intel is losing share further, pressured by customers like Google migrating to custom Axion processors for orchestration duties.

The margin story adds another layer of caution. CFO Jean Hu warned on the last earnings call that the initial ramp of the MI450 chip would pressure corporate margins, as the product launches below the company's average profitability. Insider selling has also grabbed attention: EVP Paul Darren Grasby disposed of 24,376 shares on May 8 at an average of $444, and CEO Lisa Su sold 125,000 shares in mid-May, along with EVP Forrest Norrod's nearly 20,000-share sale — all executed under preset trading plans. ARK Invest trimmed its position by 38,529 shares worth about $16.2 million across three ETFs in May, though the firm maintains AMD as a core holding.

Wall Street remains sharply divided. While 34 analysts rate the stock a buy, the average price target sits at $411.03 — roughly 21% below Friday's close. The range spans from Evercore ISI Group's bullish $579 (set on May 19) down to Citigroup's $248 (from early April). That chasm reflects a fierce debate over whether AMD can sustain its AI-driven growth trajectory.

The immediate catalyst will be the second-quarter report due in August, with guidance already set at around $11.20 billion in revenue. The market will be watching the delivery curve of the Instinct MI product family and EPYC's continued market share gains as the ultimate test of Wolfe's bullish bet. For now, the stock sits just 2% below its recent high, with the €440 level serving as technical support — but in a sector where production constraints and margin compression are constant companions, the next leg higher depends on execution, not ambition.

Ad

AMD Stock: New Analysis - 30 May

Fresh AMD information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated AMD analysis...

en | US0079031078 | AMDS | boerse | 69448889 |